JFS WEALTH ADVISORS, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 29 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JFS WEALTH ADVISORS, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$2,000
+100.0%
5000.0%0.00%
Q3 2020$1,000
-50.0%
5000.0%0.00%
-100.0%
Q2 2020$2,0000.0%5000.0%0.00%0.0%
Q1 2020$2,000
-33.3%
5000.0%0.00%0.0%
Q4 2019$3,000
+50.0%
5000.0%0.00%0.0%
Q3 2019$2,0000.0%5000.0%0.00%0.0%
Q2 2019$2,0000.0%5000.0%0.00%0.0%
Q1 2019$2,0000.0%5000.0%0.00%0.0%
Q4 2018$2,0000.0%5000.0%0.00%0.0%
Q3 2018$2,000
-50.0%
5000.0%0.00%0.0%
Q2 2018$4,000
+33.3%
5000.0%0.00%0.0%
Q1 2018$3,000
-40.0%
5000.0%0.00%0.0%
Q4 2017$5,0000.0%5000.0%0.00%0.0%
Q3 2017$5,000
-37.5%
500
-50.0%
0.00%
-50.0%
Q2 2017$8,000
+33.3%
1,0000.0%0.00%0.0%
Q1 2017$6,0000.0%1,0000.0%0.00%0.0%
Q4 2016$6,000
-14.3%
1,0000.0%0.00%0.0%
Q3 2016$7,000
-12.5%
1,0000.0%0.00%0.0%
Q2 2016$8,000
+14.3%
1,0000.0%0.00%0.0%
Q1 2016$7,000
-22.2%
1,0000.0%0.00%
-33.3%
Q4 2015$9,000
+80.0%
1,0000.0%0.00%
+50.0%
Q3 2015$5,0001,0000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 290,501$2,513,0001.83%
Knoll Capital Management, LLC 20,000$173,0000.11%
Private Portfolio Partners LLC 42,250$365,4630.09%
Rossmore Private Capital 40,661$352,0000.06%
OCCUDO QUANTITATIVE STRATEGIES LP 54,233$469,0000.04%
Cubist Systematic Strategies, LLC 241,892$2,092,0000.02%
TWO SIGMA ADVISERS, LP 662,000$5,726,0000.02%
TWO SIGMA INVESTMENTS, LP 550,956$4,766,0000.01%
Jump Financial, LLC 34,800$301,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 264,824$2,291,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders